Benzinga··Vandana SinghIndia's Generic Semaglutide Flood Slashes Ozempic Costs by 70%, Reshaping Global Obesity Market
Over 40 Indian pharma companies launched generic semaglutide after patent expiration, pricing treatments 70% below Novo Nordisk's originals. Market expansion planned globally.
NVOHIMSRDYweight loss drugsobesity market